Cerebral Vasospasm

  • R. W. Seiler
  • H.-J. Steiger

Part of the Acta Neurochirurgica Supplements book series (NEUROCHIRURGICA, volume 77)

Table of contents

  1. Front Matter
    Pages I-XI
  2. Is Cerebral Vasospasm still a Clinical Problem?

    1. R. W. Seiler, R. Binggeli
      Pages 1-4
  3. Basic Science and Experimental Vasospasm

    1. Front Matter
      Pages 5-5
    2. Molecular Biology of Vasospasm

      1. Z.-D. Zhang, L. S. Marton, S. Ono, T Komuro, B. Weir, R. L. Macdonald
        Pages 17-19
      2. S. Nishizawa, K. Obara, K. Nakayama, M. Koide, T. Yokoyama, N. Yokota et al.
        Pages 21-24
      3. A. Y. Zubkov, R. E. Tibbs, B. Clower, K. Ogihara, K. Aoki, J. H. Zhang
        Pages 29-31
      4. Z.-D. Zhang, B. Yamini, T. Komuro, S. Ono, L. Johns, L. S. Marton et al.
        Pages 33-35
      5. J. Hansen-Schwartz, G. Sviri, L. Edvinsson
        Pages 37-40
      6. G. E. Sviri, B. Shik, B. Raz, J. F. Soustiel
        Pages 41-43
      7. B. S. Jahromi, T. Komuro, R. L. Macdonald, L. S. Marton, B. K. Weir
        Pages 45-47
      8. M. Sato, E. Tani, H. Fujikawa, I. Yamaura, N. Arita, K. Kaibuchi
        Pages 49-54
      9. K. Aoki, A. Y. Zubkov, R. E. Tibbs, T. Meguro, J. H. Zhang
        Pages 55-57
    3. Endothelin and Nitric Oxide

      1. R. M. Pluta, B. G. Thompson, J. K. Afshar, R. J. Boock, B. Iuliano, E. H. Oldfield
        Pages 67-72
      2. J M. Kim, K. H. Bak, C. H. Kim, I. K. Park, S. J. Oh, H. K. Choi
        Pages 77-79
    4. Gene Therapy

      1. J. M. Findlay
        Pages 83-87

About these proceedings

Introduction

Cerebral vasospasm remains a major clinical problem in patients with subarachnoid hemorrhage. Neuroprotection with calcium antagonists, hemodynamic therapy and interventional angioplasty have an established role in the management of this disease, but an effective single drug for prevention or treatment of the vasospasm is still lacking. This book contains selected contributions to the 7th International Conference on Cerebral Vasospasm held in Interlaken, Switzerland, in June 2000. Part I of the book concentrates on basic science and experimental vasospasm. The molecular biology of vasospasm, the role of endothelin and nitric oxide as well as the potential of gene therapy are presented. Part II concentrates on the diagnosis and therapy of clinical vasospasm. New diagnostic tools are presented, including diffusion and perfusion-weighted MRI, MR spectroscopy and microdialysis with metabolic monitoring. Leaders in the field discuss the current indications and results of endovascular treatment of cerebral vasospasm. The latter chapters are devoted to the treatment of clinical vasospasm with new drugs and to the prevention and treatment of ischemic deficits with neuroprotective drugs and hemodynamic therapy. The book provides the state-of-the-art in the major subjects of the molecular biology of vasoconstriction and experimental vasospasm as well as the diagnosis and treatment of clinical vasospasm.

Keywords

cerebral vasospasm clinical vasospasm diagnosis magnetic resonance imaging (MRI) neuroprotection vasospasm

Editors and affiliations

  • R. W. Seiler
    • 1
  • H.-J. Steiger
    • 2
  1. 1.InselspitalNeurochirurgische Univ.-KlinikBernSwitzerland
  2. 2.Klinikum GroßhadernNeurochirurgische Univ.-KlinikMünchenGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-7091-6232-3
  • Copyright Information Springer-Verlag Vienna 2001
  • Publisher Name Springer, Vienna
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-211-83650-7
  • Online ISBN 978-3-7091-6232-3
  • Series Print ISSN 0065-1419
  • About this book
Industry Sectors
Biotechnology
Pharma